Agency Information Collection Activities: Proposed Collection; Comment Request, 5014-5015 [2016-01688]
Download as PDF
5014
Federal Register / Vol. 81, No. 19 / Friday, January 29, 2016 / Notices
Shoreline II, Outfitter and Guide
Management Plan), Comment Period
Ends:, 03/14/2016, Contact: Carey
Case 907–772–3871.
EIS No. 20160018, Draft, NPS, MD,
Assateague Island National Seashore
General Management Plan, Comment
Period Ends: 05/01/2016, Contact:
Deborah Darden 410–629–6080.
EIS No. 20160019, Final, USFS, OR,
Kahler Dry Forest Restoration, Review
Period Ends: 03/14/2016, Contact:
John Evans 541–278–3869.
EIS No. 20160020, Draft, USFS, CA,
Lassen National Forest Over-Snow
Vehicle (OSV) Use Designation,
Comment Period Ends: 03/15/2016,
Contact: Chris Obrien 530–252–6698.
EIS No. 20160021, Draft, USACE, NY,
Mamaroneck and Sheldrake Rivers
Flood Risk Management Village of
Mamaroneck General Reevaluation,
Comment Period Ends: 03/14/2016,
Contact: Matthew Voisine 917–790–
8718.
jstallworth on DSK7TPTVN1PROD with NOTICES
Amended Notices
EIS No. 20150312, Draft, FRA, NY, NEC
FUTURE Tier 1, Comment Period
Ends: 02/16/2016, Contact: Rebecca
Reyes-Alicea 212–668–2282, Revision
to FR Notice Published 11/13/2015;
Extending Comment Period from 01/
30/2016 to 02/16/2016.
EIS No. 20150353, Draft, FRA, MD,
Baltimore and Potomac Tunnel
Project, Comment Period Ends: 02/19/
2016, Contact: Michelle W. Fishburne
202–293–0398, Revision to FR Notice
Published 12/18/20105; Extending
Comment Period from 02/05/2016 to
02/19/2016.
EIS No. 20150358, Draft, USACE, FL,
Herbert Hoover Dike Dam Safety
Modification, Comment Period Ends:
02/23/2016, Contact: Stacie
Auvenshine 904–232–3694, Revision
to FR Notice Published 12/24/2015;
Correction to Comment Period from
02/08/2016 to 02/23/2016.
EIS No. 20160001, Final, FHWA, CO, I–
70 East, Review Period Ends: 03/02/
2016, Contact: Chris Horn 720–963–
3017, Revision to FR Notice Published
01/15/2016; Extending Comment
Period from 02/16/2016 to 03/02/
2016.
EIS No. 20160008, Draft, USFS, WY,
Withdrawn—Bear Lodge Project,
Contact: Jeanette Timm 307–283–
1361, Revision to FR Notice Published
01/15/2016; The U.S. Department of
Agriculture’s Forest Service has
Officially Withdrawn this EIS.
VerDate Sep<11>2014
12:14 Jan 28, 2016
Jkt 238001
Dated: January 26, 2016.
Dawn Roberts,
Management Analyst, NEPA Compliance
Division, Office of Federal Activities.
[FR Doc. 2016–01706 Filed 1–28–16; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–R–153]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995 (the
PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
any of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments must be received by
March 29, 2016.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
DATES:
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–R–153 Medicaid Drug Use
Review (DUR) Program
Under the PRA (44 U.S.C. 3501–
3520), federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
Section 3506(c)(2)(A) of the PRA
requires federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicaid Drug
Use Review (DUR) Program; Use: States
must provide for a review of drug
therapy before each prescription is filled
E:\FR\FM\29JAN1.SGM
29JAN1
Federal Register / Vol. 81, No. 19 / Friday, January 29, 2016 / Notices
jstallworth on DSK7TPTVN1PROD with NOTICES
or delivered to a Medicaid patient. This
review includes screening for potential
drug therapy problems due to
therapeutic duplication, drug-disease
contraindications, drug-drug
interactions, incorrect drug dosage or
duration of drug treatment, drug-allergy
interactions, and clinical abuse/misuse.
Pharmacists must make a reasonable
effort to obtain, record, and maintain
Medicaid patient profiles. These profiles
must reflect at least the patient’s name,
address, telephone number, date of
birth/age, gender, history, e.g., allergies,
drug reactions, list of medications, and
pharmacist’s comments relevant to the
individual’s drug therapy.
The State must conduct RetroDUR
which provides for the ongoing periodic
examination of claims data and other
records in order to identify patterns of
fraud, abuse, inappropriate or medically
unnecessary care. Patterns or trends of
drug therapy problems are identified
and reviewed to determine the need for
intervention activity with pharmacists
and/or physicians. States may conduct
interventions via telephone,
correspondence, or face-to-face contact.
Annual reports are submitted to CMS
for the purposes of monitoring
compliance and evaluating the progress
of States’ DUR programs. The
information submitted by States is
reviewed and results are compiled by
CMS in a format intended to provide
information, comparisons and trends
related to States’ experiences with DUR.
The States benefit from the information
and may enhance their programs each
year based on State reported innovative
practices that are compiled by CMS
from the DUR annual reports. Form
Number: CMS–R–153 (OMB Control
Number 0938–0659); Frequency: Yearly,
quarterly, and occasionally; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
51; Total Annual Responses: 510; Total
Annual Hours: 20,808. (For policy
questions regarding this collection
contact Renee Hilliard at 410–786–
2991).
Dated: January 25, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2016–01688 Filed 1–28–16; 8:45 am]
BILLING CODE 4120–01–P
VerDate Sep<11>2014
12:14 Jan 28, 2016
Jkt 238001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10519]
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
ACTION:
Notice.
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including any of the
following subjects: (1) The necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions; (2) the accuracy
of the estimated burden; (3) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(4) the use of automated collection
techniques or other forms of information
technology to minimize the information
collection burden.
DATES: Comments on the collection(s) of
information must be received by the
OMB desk officer by February 29, 2016.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
following transmissions: OMB, Office of
Information and Regulatory Affairs,
Attention: CMS Desk Officer, Fax
Number: (202) 395–5806 OR, Email:
OIRA_submission@omb.eop.gov.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, you may make your request
using one of following:
1. Access CMS’ Web site address at
https://www.cms.hhs.gov/
PaperworkReductionActof1995.
2. Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov.
SUMMARY:
PO 00000
Frm 00007
Fmt 4703
Sfmt 4703
5015
3. Call the Reports Clearance Office at
(410) 786–1326.
FOR FURTHER INFORMATION CONTACT:
Reports Clearance Office at (410) 786–
1326.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. The term ‘‘collection of
information’’ is defined in 44 U.S.C.
3502(3) and 5 CFR 1320.3(c) and
includes agency requests or
requirements that members of the public
submit reports, keep records, or provide
information to a third party. Section
3506(c)(2)(A) of the PRA (44 U.S.C.
3506(c)(2)(A)) requires federal agencies
to publish a 30-day notice in the
Federal Register concerning each
proposed collection of information,
including each proposed extension or
reinstatement of an existing collection
of information, before submitting the
collection to OMB for approval. To
comply with this requirement, CMS is
publishing this notice that summarizes
the following proposed collection(s) of
information for public comment:
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Physician
Quality Reporting System (PQRS) and
the Electronic Prescribing Incentive
(eRx) Program Data Assessment,
Accuracy and Improper Payments
Identification Support; Use: The
incentive and reporting programs have
data integrity issues, such as rejected
and improper payments. This four year
project will evaluate incentive payment
information for accuracy and identify
improper payments, with the goal of
recovering these payments.
Additionally, based on the project’s
results, recommendations will be made
so that we can avoid future data
integrity issues.
Data submission, processing, and
reporting will be analyzed for potential
errors, inconsistencies, and gaps that are
related to data handling, program
requirements, and clinical quality
measure specifications of PQRS and eRx
program. Surveys of Group Practices,
Registries, and Data Submission
Vendors (DSVs) will be conducted in
order to evaluate the PQRS and eRx
Incentive Program. Follow-up
interviews will occur with a small
number of respondents. Form Number:
CMS–10519 (OMB control number:
0938–1255); Frequency: Annually;
Affected Public: Business or other forprofits; Number of Respondents: 115;
E:\FR\FM\29JAN1.SGM
29JAN1
Agencies
[Federal Register Volume 81, Number 19 (Friday, January 29, 2016)]
[Notices]
[Pages 5014-5015]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01688]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-R-153]
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is
announcing an opportunity for the public to comment on CMS' intention
to collect information from the public. Under the Paperwork Reduction
Act of 1995 (the PRA), federal agencies are required to publish notice
in the Federal Register concerning each proposed collection of
information (including each proposed extension or reinstatement of an
existing collection of information) and to allow 60 days for public
comment on the proposed action. Interested persons are invited to send
comments regarding our burden estimates or any other aspect of this
collection of information, including any of the following subjects: (1)
The necessity and utility of the proposed information collection for
the proper performance of the agency's functions; (2) the accuracy of
the estimated burden; (3) ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) the use of
automated collection techniques or other forms of information
technology to minimize the information collection burden.
DATES: Comments must be received by March 29, 2016.
ADDRESSES: When commenting, please reference the document identifier or
OMB control number. To be assured consideration, comments and
recommendations must be submitted in any one of the following ways:
1. Electronically. You may send your comments electronically to
https://www.regulations.gov. Follow the instructions for ``Comment or
Submission'' or ``More Search Options'' to find the information
collection document(s) that are accepting comments.
2. By regular mail. You may mail written comments to the following
address: CMS, Office of Strategic Operations and Regulatory Affairs,
Division of Regulations Development, Attention: Document Identifier/OMB
Control Number, Room C4-26-05, 7500 Security Boulevard, Baltimore,
Maryland 21244-1850.
To obtain copies of a supporting statement and any related forms
for the proposed collection(s) summarized in this notice, you may make
your request using one of following:
1. Access CMS' Web site address at https://www.cms.hhs.gov/PaperworkReductionActof1995.
2. Email your request, including your address, phone number, OMB
number, and CMS document identifier, to Paperwork@cms.hhs.gov.
3. Call the Reports Clearance Office at (410) 786-1326.
FOR FURTHER INFORMATION CONTACT: Reports Clearance Office at (410) 786-
1326.
SUPPLEMENTARY INFORMATION:
Contents
This notice sets out a summary of the use and burden associated
with the following information collections. More detailed information
can be found in each collection's supporting statement and associated
materials (see ADDRESSES).
CMS-R-153 Medicaid Drug Use Review (DUR) Program
Under the PRA (44 U.S.C. 3501-3520), federal agencies must obtain
approval from the Office of Management and Budget (OMB) for each
collection of information they conduct or sponsor. The term
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA requires federal agencies
to publish a 60-day notice in the Federal Register concerning each
proposed collection of information, including each proposed extension
or reinstatement of an existing collection of information, before
submitting the collection to OMB for approval. To comply with this
requirement, CMS is publishing this notice.
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicaid Drug Use
Review (DUR) Program; Use: States must provide for a review of drug
therapy before each prescription is filled
[[Page 5015]]
or delivered to a Medicaid patient. This review includes screening for
potential drug therapy problems due to therapeutic duplication, drug-
disease contraindications, drug-drug interactions, incorrect drug
dosage or duration of drug treatment, drug-allergy interactions, and
clinical abuse/misuse. Pharmacists must make a reasonable effort to
obtain, record, and maintain Medicaid patient profiles. These profiles
must reflect at least the patient's name, address, telephone number,
date of birth/age, gender, history, e.g., allergies, drug reactions,
list of medications, and pharmacist's comments relevant to the
individual's drug therapy.
The State must conduct RetroDUR which provides for the ongoing
periodic examination of claims data and other records in order to
identify patterns of fraud, abuse, inappropriate or medically
unnecessary care. Patterns or trends of drug therapy problems are
identified and reviewed to determine the need for intervention activity
with pharmacists and/or physicians. States may conduct interventions
via telephone, correspondence, or face-to-face contact.
Annual reports are submitted to CMS for the purposes of monitoring
compliance and evaluating the progress of States' DUR programs. The
information submitted by States is reviewed and results are compiled by
CMS in a format intended to provide information, comparisons and trends
related to States' experiences with DUR. The States benefit from the
information and may enhance their programs each year based on State
reported innovative practices that are compiled by CMS from the DUR
annual reports. Form Number: CMS-R-153 (OMB Control Number 0938-0659);
Frequency: Yearly, quarterly, and occasionally; Affected Public: State,
Local, or Tribal Governments; Number of Respondents: 51; Total Annual
Responses: 510; Total Annual Hours: 20,808. (For policy questions
regarding this collection contact Renee Hilliard at 410-786-2991).
Dated: January 25, 2016.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office of Strategic Operations and
Regulatory Affairs.
[FR Doc. 2016-01688 Filed 1-28-16; 8:45 am]
BILLING CODE 4120-01-P